OneSight EssilorLuxottica Foundation se une à Organização Mundial da Saúde para impulsionar globalmente os cuidados com a visão dentro da iniciativa SPECS 2030
06. Dezember 2024 06:45 ET
|
EssilorLuxottica Media Relations
OneSight EssilorLuxottica Foundation se une à Organização Mundial da Saúde para impulsionar globalmente os cuidados com a visão dentro da iniciativa SPECS 2030 Paris, França, 6 Dezembro de 2024 – A...
OneSight EssilorLuxottica Foundation s’associe avec l’Organisation Mondiale de la Santé pour améliorer la santé visuelle sur le plan mondial, dans le cadre de l’initiative SPECS 2030
06. Dezember 2024 06:45 ET
|
EssilorLuxottica Media Relations
OneSight EssilorLuxottica Foundation s’associe avec l’Organisation Mondiale de la Santé pour améliorer la santé visuelle sur le plan mondial, dans le cadre de l’initiative SPECS 2030 de l’OMS Paris,...
La OneSight EssilorLuxottica Foundation firma un accordo di collaborazione con l’Organizzazione Mondiale della Sanità nell’ambito dell’iniziativa SPECS 2030, per promuovere la cura della vista a livello globale
06. Dezember 2024 06:45 ET
|
EssilorLuxottica Media Relations
La OneSight EssilorLuxottica Foundation firma un accordo di collaborazione con l’Organizzazione Mondiale della Sanità nell’ambito dell’iniziativa SPECS 2030, per promuovere la cura della vista a...
OneSight EssilorLuxottica Foundation se une a la Organización Mundial de la Salud para impulsar los cuidados globales de la visión bajo la iniciativa SPECS 2030 de la OMS
06. Dezember 2024 06:45 ET
|
EssilorLuxottica Media Relations
OneSight EssilorLuxottica Foundation se une a la Organización Mundial de la Salud para impulsar los cuidados globales de la visión bajo la iniciativa SPECS 2030 de la OMS Paris, Francia, 6...
OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative
06. Dezember 2024 06:45 ET
|
EssilorLuxottica Media Relations
OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative Paris, France and Geneva, Switzerland (6 December 2024)...
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
15. Oktober 2024 05:30 ET
|
Boehringer Ingelheim Limited
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare...
Queen Mathilde of Belgium, Prince Harry, Duke of Sussex, Forest Whitaker, UN Agency Heads and other dignitaries join survivors and advocates for ending child violence in New York, during the UN General Assembly
23. September 2024 00:21 ET
|
Project Everyone
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Queen Mathilde of Belgium, Prince Harry, Duke of Sussex, UN Agency Heads and other dignitaries met survivors and advocates for ending violence against...
Global Virus Network’s Annual Meeting Fortifies Bonds on the African Continent to Catalyze Innovative Research, Strengthen Pandemic Preparedness, and Combat Scientific Misinformation
18. September 2024 11:15 ET
|
Global Virus Network
DURBAN, South Africa, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Global Virus Network concluded its annual meeting of closed scientific sessions held 16-18 September 2024 with a press conference....
UN-backed open letter - including signatories Gillian Anderson and Forest Whitaker - calls on governments to confront the alarming crisis of violence impacting 1 in 2 children worldwide
17. September 2024 00:00 ET
|
Project Everyone
LONDON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Survivors, experts and advocates from around the world are launching a global effort to tackle the shocking issue of violence against children. They have...
CORRECTION: The Global Virus Network (GVN) Escalates MPOX Emergency Response Across Africa and Beyond
02. September 2024 00:47 ET
|
Global Virus Network
TAMPA, Fla., Sept. 02, 2024 (GLOBE NEWSWIRE) -- A correction has been issued for the release disseminated on August 16th. Sten Vermund's full title was corrected to Sten Vermund, MD, PhD, GVN...